Program Highlight: Workshops!

DEVELOPING SEP MARKETS & PARTNERSHIPS: CELLULAR & BEYOND

The panel will address SEP markets from cellular to IoT, Consumer Electronics, Automotive, Video Streaming and technologies including 5G and 6G, HEVC and VVC, WiFi, and more.

Top industry practitioners from leading SEP licensors, licensees, and market makers will discuss the latest views, key issues and direction forward for the industry, while top researchers will discuss the results of new research into the nature of collaboration and competition among partners in these markets.

The panel will provide ample time for audience Q&A to address attendees most pressing issues.

How to Streamline Access to Patient Materials and Data Across Entities to Accelerate Strategic Partnerships and Development of New Medicines

Access to materials, including patient samples, is critical for clinically-relevant research and development of diagnostics, therapeutics, and healthcare solutions. Mired in varied policies and guidelines of different non-profit and for-profit entities within as well as across geographies, negotiations and contractual delays are a significant roadblock for R&D efforts to combat unmet patient needs. In this workshop, leaders and founders will present pragmatic approaches and unique solutions to streamline access to materials across barriers. By facilitating faster materials and data sharing legally, scientists, patients, patient-advocates, and companies will be empowered to develop and deploy life-saving solutions.

Valuation to Power Deals & Litigation Decisions: Time is Money

Time and risk are critical factors in both IP deal-making and litigation, yet its impact on valuation is often oversimplified or overlooked. This interactive workshop examines how timing and various risk factors affects the value of IP across different scenarios. Through practical examples, we’ll explore key considerations that can significantly impact deal outcomes and litigation strategies.

Our expert panel will demonstrate how to effectively incorporate time value of money and risk factors into valuation analyses, including:

New portfolio acquisitions
Companywide vs program discount rates
Financial decisions relating to soft licensing and litigation
How to assess when to settle a litigation and at what value

Participants will learn practical techniques for quantifying time-based finance and risk factors and communicating their significance to stakeholders. Our panellists will share their experiences in addressing these challenges, offering concrete strategies that participants can apply in their own practice. Whether you’re involved in licensing negotiations, litigation, or strategic IP planning, understanding how to properly assess and communicate time-based factors is crucial for optimizing outcomes.